Literature DB >> 28168383

Correlation of rs9331888 polymorphism with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review.

Bin Zhu1, Rui Min Wang2, Jian Ting Wang3, Rui Ling Chen1, Yan Fei Zheng4, Lei Zhang5, Zhi Gang Zhao6.   

Abstract

Clusterin polymorphism (rs9331888) was reported to be associated with the susceptibility to alzheimer's disease (AD). Nevertheless, the results were inconclusive. To derive a more precise estimation of this association, this meta-analysis was conducted. We've conducted a comprehensive search of PubMed, Embase, CNKI and AlzGene database for case-control studies published throughout October, 2016 that evaluated the role of rs9331888 gene variants in AD patients. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated to assess the strength of associations between the rs9331888/C > G polymorphism and AD disease. A total of 9 studies were enrolled in the Meta Analysis. The overall analysis revealed a significant association between the rs9331888/C > G polymorphism and AD disease in the recessive model (GG vs. GC + CC: OR = 1.11, 95% CI: 1.05-1.18; P < 0.01). Sub-group analysis revealed that the Caucasian populations which with recessive model (GG vs. GC + CC: OR = 1.12, 95% CI: 1.06-1.2; P < 0.01) were dramatically related to AD, while no significant association was found in the Chinese populations among the five genetic models. Our meta-analysis demonstrated that the rs9331888/C > G polymorphism in the clusterin gene might contribute to AD susceptibility especially in Caucasian populations. Whereas the relationship of the polymorphism to the disease in Chinese populations was still in controversial. Additional well-designed studies, with larger sample sizes, are required to further elucidate this association.

Entities:  

Keywords:  Alzheimer’s disease; Clusterin; Polymorphism; rs933188

Mesh:

Substances:

Year:  2017        PMID: 28168383     DOI: 10.1007/s11011-017-9957-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  23 in total

1.  Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease.

Authors:  Jin-Tai Yu; Lu Li; Qi-Xiu Zhu; Qun Zhang; Wei Zhang; Zhong-Chen Wu; Jun Guan; Lan Tan
Journal:  Clin Chim Acta       Date:  2010-06-22       Impact factor: 3.786

2.  Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease.

Authors:  Shen-Ji Lu; Hong-Lei Li; Yi-Min Sun; Zhi-Jun Liu; Ping Yang; Zhi-Ying Wu
Journal:  Neurobiol Aging       Date:  2014-05-29       Impact factor: 4.673

Review 3.  Alzheimer's disease.

Authors:  Philip Scheltens; Kaj Blennow; Monique M B Breteler; Bart de Strooper; Giovanni B Frisoni; Stephen Salloway; Wiesje Maria Van der Flier
Journal:  Lancet       Date:  2016-02-24       Impact factor: 79.321

Review 4.  Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.

Authors:  Xiang Li; Yifei Ma; Xu Wei; Yanpeng Li; Huijuan Wu; Jianhua Zhuang; Zhongxin Zhao
Journal:  Neurosci Bull       Date:  2013-12-19       Impact factor: 5.203

5.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566

6.  Alzheimer risk variant CLU and brain function during aging.

Authors:  Madhav Thambisetty; Lori L Beason-Held; Yang An; Michael Kraut; Michael Nalls; Dena G Hernandez; Andrew B Singleton; Alan B Zonderman; Luigi Ferrucci; Simon Lovestone; Susan M Resnick
Journal:  Biol Psychiatry       Date:  2012-07-15       Impact factor: 13.382

7.  No diagnostic value of plasma clusterin in Alzheimer's disease.

Authors:  Edina Silajdžić; Lennart Minthon; Maria Björkqvist; Oskar Hansson
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

8.  Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.

Authors:  Yuan Zhou; Ikuo Hayashi; Jacky Wong; Katherine Tugusheva; John J Renger; Celina Zerbinatti
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

9.  A novel approach for multi-SNP GWAS and its application in Alzheimer's disease.

Authors:  Paul M Bodily; M Stanley Fujimoto; Justin T Page; Mark J Clement; Mark T W Ebbert; Perry G Ridge
Journal:  BMC Bioinformatics       Date:  2016-07-25       Impact factor: 3.169

10.  Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.

Authors:  A Lacour; A Espinosa; E Louwersheimer; S Heilmann; I Hernández; S Wolfsgruber; V Fernández; H Wagner; M Rosende-Roca; A Mauleón; S Moreno-Grau; L Vargas; Y A L Pijnenburg; T Koene; O Rodríguez-Gómez; G Ortega; S Ruiz; H Holstege; O Sotolongo-Grau; J Kornhuber; O Peters; L Frölich; M Hüll; E Rüther; J Wiltfang; M Scherer; S Riedel-Heller; M Alegret; M M Nöthen; P Scheltens; M Wagner; L Tárraga; F Jessen; M Boada; W Maier; W M van der Flier; T Becker; A Ramirez; A Ruiz
Journal:  Mol Psychiatry       Date:  2016-03-15       Impact factor: 15.992

View more
  1 in total

1.  Correlation of PICALM polymorphism rs3851179 with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review.

Authors:  Bin Zhu; Li-Xia Li; Lei Zhang; Shu Yang; Yue Tian; Shan-Shan Guo; Wei Zhang; Zhi-Gang Zhao
Journal:  Metab Brain Dis       Date:  2018-07-23       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.